KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Payables: 2018-2025

Historic Payables for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $11.1 million.

  • Twist Bioscience's Payables rose 580.61% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.6 million, marking a year-over-year increase of 53.26%. This contributed to the annual value of $11.1 million for FY2025, which is 580.61% up from last year.
  • Twist Bioscience's Payables amounted to $11.1 million in FY2025, which was up 580.61% from $1.6 million recorded in FY2024.
  • Twist Bioscience's Payables' 5-year high stood at $20.1 million during FY2022, with a 5-year trough of $1.6 million in FY2024.
  • For the 2-year period, Twist Bioscience's Payables averaged around $6.4 million, with its median value being $6.4 million (2024).
  • Data for Twist Bioscience's Payables shows a peak YoY spiked of 580.61% (in 2025) over the last 5 years.
  • Over the past 4 years, Twist Bioscience's Payables (Yearly) stood at $14.9 million in 2021, then surged by 34.85% to $20.1 million in 2022, then reached $1.6 million in 2024, then skyrocketed by 580.61% to $11.1 million in 2025.